Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kurt Stocker

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Frontiers in Pharmacology|August 12, 2022
Buddhist-like opposite diminishing and non-judging during ketamine infusion are associated with antidepressant response: an open-label personalized-dosing studyKurt Stocker, Matthias Hartmann, Steffen Reissmann, et al.
Journal of Psychopharmacology (Oxford, England)|October 31, 2023
The revival of the psychedelic experience scale: Revealing its extended-mystical, visual, and distressing experiential spectrum with LSD and psilocybin studiesKurt Stocker, Matthias Hartmann, Laura Ley, et al.
International Journal of Methods in Psychiatric Research|April 26, 2026
Integrating the Mystical Experience Questionnaire Into a Broader Psychometric Framework: English Validation of the Psychedelic Experience Scale and Comparison of Psilocybin and LSD Sessions Across Two Controlled SettingsKurt Stocker, Matthias Hartmann, Frederick S Barrett, et al.
Journal of Psychopharmacology (Oxford, England)|December 26, 2025
The 3D-ASCr scale: A revalidation of the core dimensions of the Altered States of Consciousness Rating Scale 5D(11)-ASC for psychedelic researchKurt Stocker, Matthias Hartmann, Yasmin Schmid, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Frontiers in Pharmacology|August 12, 2022
Buddhist-like opposite diminishing and non-judging during ketamine infusion are associated with antidepressant response: an open-label personalized-dosing studyKurt Stocker, Matthias Hartmann, Steffen Reissmann, et al.
Journal of Psychopharmacology (Oxford, England)|October 31, 2023
The revival of the psychedelic experience scale: Revealing its extended-mystical, visual, and distressing experiential spectrum with LSD and psilocybin studiesKurt Stocker, Matthias Hartmann, Laura Ley, et al.
International Journal of Methods in Psychiatric Research|April 26, 2026
Integrating the Mystical Experience Questionnaire Into a Broader Psychometric Framework: English Validation of the Psychedelic Experience Scale and Comparison of Psilocybin and LSD Sessions Across Two Controlled SettingsKurt Stocker, Matthias Hartmann, Frederick S Barrett, et al.
Journal of Psychopharmacology (Oxford, England)|December 26, 2025
The 3D-ASCr scale: A revalidation of the core dimensions of the Altered States of Consciousness Rating Scale 5D(11)-ASC for psychedelic researchKurt Stocker, Matthias Hartmann, Yasmin Schmid, et al.
Pageof 2